3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Dermatologic
1
Conditions
Prostatic Neoplasms
11
Urinary Bladder Neoplasms
2
Male Urogenital Diseases
2
Pain, Postoperative
1
Inflammation
1
Interventions
palbociclib
1
Tea
1
Sufentanil
1
Rivaroxaban
1
Morphine
1
Atorvastatin
1
Analgesia, Patient-Controlled
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Inflammation
×
Tea
×
Genitourinary
×
Clear all
NCT01367418
2012-03-19
AIMS
Örebro University, Sweden
Phase 3
Completed
26 enrolled